VANCOUVER, March 27 /PRNewswire-FirstCall/ -- AnorMED Inc. (TSX: AOM) announced that it will hold a conference call and web cast today, Monday March 27, 2006 at 9:00 a.m. EST (6:00 a.m. PST) to discuss its recommendation to support the current AnorMED Management Team and Proposed Slate of Directors and reject The Baker Group's proposed slate. The web cast can be accessed through the company's web site at http://www.anormed.com/. To listen to the teleconference please dial 1-800-558-5253 in Canada and the U.S. or 1-416-626-4100 Internationally at 9:00 am EST. The reservation number required for access is No. 21288034. Participants will be in listen only mode. This call will be available on replay until April 26, 2006. AnorMED is a chemistry- based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. Information on AnorMED Inc. is available on the Company's website: http://www.anormed.com/. For further information: Elisabeth Whiting, M.Sc., Vice President, Corporate Development & Communications, Tel: (604) 532-4667, e-mail: DATASOURCE: AnorMED Inc. CONTACT: Elisabeth Whiting, M.Sc., Vice President, Corporate Development & Communications, Tel: (604) 532-4667, e-mail:

Copyright